Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study

BACKGROUND: Pazopanib has activity in relapsed non-adipocytic soft-tissue sarcomas (STS). A series of serum cytokines and angiogenic factors (CAFs) at baseline and changes in soluble vascular endothelial growth factor receptor-2 (sVEGFR2) or placental-derived growth factor (PlGF) levels during treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sleijfer, S, Gorlia, T, Lamers, C, Burger, H, Blay, J-Y, Le Cesne, A, Scurr, M, Collin, F, Pandite, L, Marreaud, S, Hohenberger, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419967/
https://www.ncbi.nlm.nih.gov/pubmed/22805326
http://dx.doi.org/10.1038/bjc.2012.328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419967/
https://www.ncbi.nlm.nih.gov/pubmed/22805326
http://dx.doi.org/10.1038/bjc.2012.328

Ejemplares similares